Cytolytic T cell reactivity to Epstein-Barr virus is lost during in vitro T cell expansion

Journal of Hematotherapy and Stem Cell Research

Volumn 11, Issue 4, 2002, Pages 669-674

  Carlens, S ^a   Liu, D ^a   Ringden O ^a   Aschan, J ^a   Christensson, B ^a   Levitsky, V ^a   Dilber, M S ^a  

^a KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

ALLOIMMUNITY; ARTICLE; BONE MARROW CELL; CYTOTOXIC T LYMPHOCYTE; EPSTEIN BARR VIRUS; FLUORESCENCE ACTIVATED CELL SORTING; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMAN; HUMAN CELL; IMMUNOCOMPETENCE; LYMPHOCYTE CULTURE; LYMPHOPROLIFERATIVE DISEASE; MONONUCLEAR CELL; PRIORITY JOURNAL; T LYMPHOCYTE ACTIVATION; TARGET CELL; VIRUS REACTIVATION;

CELL CULTURE TECHNIQUES; CELLS, CULTURED; CYTOTOXICITY, IMMUNOLOGIC; EPSTEIN-BARR VIRUS INFECTIONS; FLOW CYTOMETRY; HEMATOPOIETIC STEM CELL MOBILIZATION; HERPESVIRUS 4, HUMAN; HUMANS; INTERLEUKIN-2; MUROMONAB-CD3; STEM CELL TRANSPLANTATION; T-LYMPHOCYTES; T-LYMPHOCYTES, CYTOTOXIC; TIME FACTORS;

EID: 0036330361     PISSN: 15258165     EISSN: None     Source Type: Journal    
DOI: 10.1089/15258160260194811     Document Type: Article

References (21)

1. Malignancies after hematopoietic stem cell transplantation: Many questions, some answers
2. Risk of lymphoproliferative disorders after bone marrow transplantation: A multi-institutional study
3. The development of cellular immunity to Epstein-Barr virus after allogeneic bone marrow transplantation
4. Ganciclovir treatment of herpes simplex thymidine kinase-transduced primary T lymphocytes: An approach for specific in vivo donor T-cell depletion after bone marrow transplantation?
5. In vivo alloreactive potential of ex vivo-expanded primary T lymphocytes
6. Administration of herpes simplex-thymidine kinase-expressing donor T cells with a T-cell-depleted allogeneic marrow graft
7. Release of infectious Epstein-Barr virus by transformed marmoset leukocytes
8. Differential recognition of tumor-derived and in vitro Epstein-Barr virus-transformed B-cell lines by fetal calf serum-specific T4-positive cytotoxic T-lymphocyte clones
9. Differentiation-dependent sensitivity of human B-cell-derived lines to major histocompatibility complex-restricted T-cell cytotoxicity
10. Ex vivo T lymphocyte expansion for retroviral transduction. Influence of serum-free media on variations in cell expansion rates and lymphocyte subset distribution
11. Regulation of T cell subsets from naive to memory
12. Mature T lymphocyte apoptosis-immune regulation in a dynamic and unpredictable antigenic environment
13. CD28 can promote T cell survival through a phosphatidylinositol 3-kinase-independent mechanism
14. Up-regulation of c-FLIPshort and reduction of activation-induced cell death in CD28-costimulated human T cells
15. Loss of CD28 expression on CD8(+) T cells is induced by IL-2 receptor gamma chain signalling cytokines and type I IFN, and increases susceptibility to activation-induced apoptosis
16. Anti-B-cell monoclonal antibodies in the treatment of severe B-cell lymphoproliferative syndrome following bone marrow and organ transplantation
17. Risks of developing Epstein-Barr virus-related lymphoproliferative disorders after T-cell-depleted marrow transplants. CAMPATH Users
18. Prevention of EBV-induced B-lymphoproliferative disorder by ex vivo marrow B-cell depletion in HLA-phenoidentical or non-identical T-depleted bone marrow transplantation
19. Infusion of cytotoxic T cells for the prevention and treatment of Epstein-Barr virus-induced lymphoma in allogeneic transplant recipients
20. Transfer of EBV-specific CTL to prevent EBV lymphoma post bone marrow transplant
21. Epstein-Barr virus (EBV) load in bone marrow transplant recipients at risk to develop posttransplant lymphoproliferative disease: Prophylactic infusion of EBVspecific cytotoxic T cells